Clinical Trial

POCT Detection for Blood Concentration of Tirofiban in Acute Myocardial Infarction Based on Azo-POP Probe.

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated March 25, 2025 (before its estimated July 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to monitor blood drug concentration during the use of tirofiban, predict the occurrence of intraoperative and postoperative complications related to interventional therapy, and evaluate the efficacy of multiple antiplatelet drugs.The main question it aims to answer is: 1. If the POCT detection technology for blood concentration of tirofiban based on portable mass spectrometer can be used for on-site sampling, clinical testing, and immediate analysis next to patients undergoing coronary intervention therapy. 2. LC-MS/MS untargeted metabolomics analysis techniques combined with machine learning algorithms will be used to screen biomarkers for myocardial infarction.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-19.
Trial Details
NCT Number NCT06836531
Lead Sponsor First Affiliated Hospital of Ningbo University
Conditions Acute Myocardial Infarction (AMI)
Enrollment 100 participants
Start Date 2025-03-30
Primary Completion 2025-07-31 (estimated)
Study Completion 2025-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-25